论文信息 - Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events. - 字舞流文

Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events.

Y. Yazdanpanah | C. Londner | B. Fantin | J. Lelièvre | B. Crestani | E. Caumes | N. Veziris | J. Robert | S. Tunesi | A. Hummel | F. Mechaï | B. Wyplosz | G. Pialoux | K. Lacombe | J. Meynard | S. Gallien | P. Sellier | A. Aubry | S. Bulifon | A. Morin | N. Fortineau | A. Ferroni | É. Catherinot | P. Morand | P. Loulergue | E. Carbonnelle | V. Lalande | L. Lassel | J. Decousser | C. Verdet | S. Abgrall | N. Lemaître | N. Grall | A. Munier | C. Le Jeunne | F. Mougari | J. Jaffré | C. Rioux | N. de Castro | M. Lafaurie | V. Pourcher | T. Billard-Pomares | A. Roux | B. Nebbad-Lechani | E. Bille | B. Denis | L. Guglielmetti | C. Pierre-Audigier | J. Pavie | J. Molina | F. Schramm | Sheila Chiesi | D. Le Dû | D. Marigot-Outtandy | V. Delcey | E. Lécorché | R. Guery | F. Morel | M. Jachym | N. Lemaitre | N. Roche | L. Deconinck | J. Lourenço | V. Chambrin | Marwa Bachir | Hugo Langris | O. Bouchaud | H. Nunes | M. Pellan | C. Dumesnil | J. Dumoulin | C. Guillet | A. Galy | F. Cohen | I. Bonnet | A. Canestri | A. Nardi | M. Gominet | N. De Castro | N. Lemaître | Typhaine Billard-Pomares | T. Billard-Pomares

[1] M. Pai,et al. Isoniazid-resistant tuberculosis: A problem we can no longer ignore , 2020, PLoS medicine.

[2] K. Floyd,et al. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data , 2020, PLoS medicine.

[3] Ross J. Harris,et al. Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance , 2019, European Respiratory Journal.

[4] J. Campbell,et al. The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study , 2019, PloS one.

[5] M. C. Schechter,et al. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009‐2014 , 2017, Annals of the American Thoracic Society.

[6] A. Benedetti,et al. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.

[7] L. Ferreyra-Reyes,et al. Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010 , 2016, PloS one.

[8] J. M. E. Bouza,et al. Brote de tuberculosis resistente a isoniacida en una comunidad de inmigrantes en España , 2016 .

[9] H. Jenkins,et al. Global and Regional Burden of Isoniazid-Resistant Tuberculosis , 2015, Pediatrics.

[10] V. Jarlier,et al. Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in France. , 2012, The Journal of infection.

[11] T. Cohen,et al. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12] A. Shetty,et al. Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients , 2012, Scandinavian journal of infectious diseases.

[13] T. Victor,et al. Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14] H. Jenkins,et al. Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009 , 2011, PloS one.

[15] E. Wileyto,et al. Isoniazid-Resistant Tuberculous Meningitis, United States, 1993–2005 , 2011, Emerging infectious diseases.

[16] V. Thomsen,et al. Isoniazid-resistant tuberculosis in Denmark: mutations, transmission and treatment outcome. , 2010, The Journal of infection.

[17] A. Benedetti,et al. Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis , 2009, PLoS medicine.

[18] V. Jarlier,et al. An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001–2002 , 2006, European Journal of Epidemiology.

[19] F. Drobniewski,et al. Outbreak of isoniazid resistant tuberculosis in north London , 2002, Thorax.

[20] M. Munang,et al. Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999-2010. , 2015, QJM : monthly journal of the Association of Physicians.